Every Shalby Ltd filing with the NSE and BSE that Blacklitt has written about, explained in plain words and linked to the filing, newest first: legal, earnings, management change.
5 articles · Healthcare services · Latest 3 Nov 2026
Shalby (NSE: SHALBY) reported consolidated total income of ₹318.22 crore and consolidated net profit of ₹7.89 crore for the quarter ended 30 Sep 2026, and standalone total income of ₹250.61 crore and standalone net profit of ₹23.50 crore, according to its results released on 3 Nov 2026.
The CMHO, Jabalpur, permitted the hospital to resume admissions on the previously affected floor after renovation and safety measures; the company is listed at ₹1,319 crore by market value.
Shalby Limited has told the exchanges that the Chief Medical and Health Officer, Jabalpur, has withdrawn the suspension of the registration of Shalby Hospital, Jabalpur, in a letter dated 17 Oct 2026. The hospital is permitted to resume its regular healthcare services, including admitting patients, subject to the conditions set by the authority.
Shalby Limited has told the exchanges that the Chief Medical and Health Officer (CMHO), Jabalpur, has ordered the suspension of the registration of Shalby Hospital, Jabalpur, pending reassessment and the submission of the prescribed fire safety and electrical safety inspection reports. The order is dated 12 Oct 2026, and the company received it on 13 Oct 2026. The company made the disclosure on 14 Oct 2026 under Regulation 30 of the SEBI listing rules.